Vimarsana
Biggest News Aggregation in the World

Page 4 - Advanced Solid Tumors News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Advanced Solid Tumors. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Advanced Solid Tumors Today - Breaking & Trending Today

Dr Pachynski on the Ongoing Investigation of ARX517 in Advanced Solid Tumors - Vimarsana News

Dr Pachynski on the Ongoing Investigation of ARX517 in Advanced Solid Tumors

Russell Pachynski, MD, discusses the ongoing investigation of ARX517 in patients with advanced solid tumors in the phase 1/2 APEX-01 trial.

Xilio Therapeutics Announces Upcoming Presentations at the Society for Immunotherapy of Cancer's (SITC) 38th Annual Meeting - Xilio Therapeutics (NASDAQ:XLO) - Vimarsana News

Xilio Therapeutics Announces Upcoming Presentations at the Society for Immunotherapy of Cancer's (SITC) 38th Annual Meeting - Xilio Therapeutics (NASDAQ:XLO)

WALTHAM, Mass., Sept. 27, 2023 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (NASDAQ:XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living

ProfoundBio Announces Upcoming Scientific Presentations at SITC 2023 - Vimarsana News

ProfoundBio Announces Upcoming Scientific Presentations at SITC 2023

SEATTLE, Sept. 28, 2023 /PRNewswire/ -- ProfoundBio, a clinical-stage biotechnology company focused on the development of novel antibody-drug conjugate

Xilio Therapeutics Announces Upcoming Presentations at the - Vimarsana News

Xilio Therapeutics Announces Upcoming Presentations at the

WALTHAM, Mass., Sept. 27, 2023 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and...

Xilio Therapeutics Announces Upcoming Presentations at the Society for Immunotherapy of Cancer's (SITC) 38th Annual Meeting - Vimarsana News

Xilio Therapeutics Announces Upcoming Presentations at the Society for Immunotherapy of Cancer's (SITC) 38th Annual Meeting

WALTHAM, Mass., Sept. 27, 2023 -- Xilio Therapeutics, Inc. , a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with...